Literature DB >> 23183891

Contribution of intracellular ATP to cisplatin resistance of tumor cells.

Verena Schneider1, Michaela L Krieger, Gerd Bendas, Ulrich Jaehde, Ganna V Kalayda.   

Abstract

Decreased cellular accumulation of cisplatin is a frequently observed mechanism of resistance to the drug. Beside passive diffusion, several cellular proteins using ATP hydrolysis as an energy source are assumed to be involved in cisplatin transport in and out of the cell. This investigation aimed at clarifying the contribution of intracellular ATP as an indicator of energy-dependent transport to cisplatin resistance using the A2780 human ovarian adenocarcinoma cell line and its cisplatin-resistant variant A2780cis. Depletion of intracellular ATP with oligomycin significantly decreased cellular platinum accumulation (measured by flameless atomic absorption spectrometry) in sensitive but not in resistant cells, and did not affect cisplatin efflux in both cell lines. Inhibition of Na(+),K(+)-ATPase with ouabain reduced platinum accumulation in A2780 cells but to a lesser extent compared with oligomycin. Western blot analysis revealed lower expression of Na(+),K(+)-ATPase α(1) subunit in resistant cells compared with sensitive counterparts. The basal intracellular ATP level (determined using a bioluminescence-based assay) was significantly higher in A2780cis cells than in A2780 cells. Our results highlight the importance of ATP-dependent transport, among other processes mediated by Na(+),K(+)-ATPase, for cisplatin influx in sensitive cells. Cellular platinum accumulation in resistant cells is reduced and less dependent on energy sources, which may partly result from Na(+),K(+)-ATPase downregulation. Our data suggest the involvement of other ATP-dependent processes beside those regulated by Na(+),K(+)-ATPase. Higher basal ATP level in cisplatin-resistant cells, which appears to be a consequence of enhanced mitochondrial ATP production, may represent a survival mechanism established during development of resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183891     DOI: 10.1007/s00775-012-0960-6

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  50 in total

Review 1.  The Na,K-ATPase.

Authors:  J C Skou; M Esmann
Journal:  J Bioenerg Biomembr       Date:  1992-06       Impact factor: 2.945

Review 2.  The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.

Authors:  Matthew D Hall; Mitsunori Okabe; Ding-Wu Shen; Xing-Jie Liang; Michael M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

3.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

4.  Covalent binding of cisplatin impairs the function of Na(+)/K(+)-ATPase by binding to its cytoplasmic part.

Authors:  Miroslav Huličiak; Jan Vacek; Marek Sebela; Eva Orolinová; Joanna Znaleziona; Marika Havlíková; Martin Kubala
Journal:  Biochem Pharmacol       Date:  2012-02-27       Impact factor: 5.858

5.  Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells.

Authors:  Yunfei Zhou; Federico Tozzi; Jinyu Chen; Fan Fan; Ling Xia; Jinrong Wang; Guang Gao; Aijun Zhang; Xuefeng Xia; Heather Brasher; William Widger; Lee M Ellis; Zhang Weihua
Journal:  Cancer Res       Date:  2011-11-14       Impact factor: 12.701

6.  Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.

Authors:  D W Shen; S Goldenberg; I Pastan; M M Gottesman
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

7.  Determination of platinum complexes in clinical samples by a rapid flameless atomic absorption spectrometry assay.

Authors:  C Kloft; H Appelius; W Siegert; W Schunack; U Jaehde
Journal:  Ther Drug Monit       Date:  1999-12       Impact factor: 3.681

8.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.

Authors:  S P Crouch; R Kozlowski; K J Slater; J Fletcher
Journal:  J Immunol Methods       Date:  1993-03-15       Impact factor: 2.303

9.  Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination.

Authors:  R L Stolfi; J R Colofiore; L D Nord; J A Koutcher; D S Martin
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

10.  Active efflux system for cisplatin in cisplatin-resistant human KB cells.

Authors:  R Fujii; M Mutoh; K Niwa; K Yamada; T Aikou; M Nakagawa; M Kuwano; S Akiyama
Journal:  Jpn J Cancer Res       Date:  1994-04
View more
  10 in total

Review 1.  Extracellular ATP and Macropinocytosis: Their Interactive and Mutually Supportive Roles in Cell Growth, Drug Resistance, and EMT in Cancer.

Authors:  Maria Evers; Jingwen Song; Xiaozhuo Chen
Journal:  Subcell Biochem       Date:  2022

2.  Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation.

Authors:  Malvika H Solanki; Prodyot K Chatterjee; Madhu Gupta; Xiangying Xue; Andrei Plagov; Margot H Metz; Rachel Mintz; Pravin C Singhal; Christine N Metz
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-18

3.  Transporter-Mediated Interaction Between Platinum Drugs and Sorafenib at the Cellular Level.

Authors:  Verena Schneider; Selim Chaib; Claudia Spanier; Mandy Knapp; Violeta Moscvin; Laura Scordovillo; Alessandra Ewertz; Ulrich Jaehde; Ganna V Kalayda
Journal:  AAPS J       Date:  2017-11-30       Impact factor: 4.009

4.  Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.

Authors:  Lynda M McEvoy; Sharon A O'Toole; Cathy D Spillane; Cara M Martin; Michael F Gallagher; Britta Stordal; Gordon Blackshields; Orla Sheils; John J O'Leary
Journal:  BMC Cancer       Date:  2015-07-25       Impact factor: 4.430

5.  Chemotherapy with cisplatin: insights into intracellular pH and metabolic landscape of cancer cells in vitro and in vivo.

Authors:  Marina V Shirmanova; Irina N Druzhkova; Maria M Lukina; Varvara V Dudenkova; Nadezhda I Ignatova; Ludmila B Snopova; Vladislav I Shcheslavskiy; Vsevolod V Belousov; Elena V Zagaynova
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

6.  [Metabolomics Study on the Differences of Endogenous Small Molecule 
between A549/DDP and A549 Cells Based on High Solution UPLC-TOF-MS].

Authors:  Weipeng Hong; Yonghua Zhao; Lin Cao; Di Cao; Zhongxiang Zhao; Jing Jin
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-08-20

Review 7.  Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin.

Authors:  Sarah Spreckelmeyer; Chris Orvig; Angela Casini
Journal:  Molecules       Date:  2014-09-29       Impact factor: 4.411

Review 8.  Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches.

Authors:  Talha Bin Emran; Asif Shahriar; Aar Rafi Mahmud; Tanjilur Rahman; Mehedy Hasan Abir; Mohd Faijanur-Rob Siddiquee; Hossain Ahmed; Nova Rahman; Firzan Nainu; Elly Wahyudin; Saikat Mitra; Kuldeep Dhama; Mahmoud M Habiballah; Shafiul Haque; Ariful Islam; Mohammad Mahmudul Hassan
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

9.  Drug resistance and combating drug resistance in cancer.

Authors:  Xuan Wang; Haiyun Zhang; Xiaozhuo Chen
Journal:  Cancer Drug Resist       Date:  2019-06-19

10.  Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase.

Authors:  Xuan Wang; Yunsheng Li; Yanrong Qian; Yanyang Cao; Pratik Shriwas; Haiyun Zhang; Xiaozhuo Chen
Journal:  Oncotarget       Date:  2017-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.